BlackRock Portfolio holdings
BlackRock, Inc., founded in 1988 by Larry Fink and a group of partners, is the world’s largest asset management firm, headquartered in New York City. Initially starting as a risk management and fixed-income institutional asset manager, it has grown to manage over $10 trillion in assets through a combination of organic growth and strategic acquisitions, such as its 2009 purchase of Barclays Global Investors. BlackRock is known for its extensive range of investment products, including mutual funds, ETFs (notably under the iShares brand), and alternative investments, serving clients ranging from individuals to governments.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$2.16B |
| 2 |
AbbVie
ABBV
|
+$1.93B |
| 3 |
Regeneron Pharmaceuticals
REGN
|
+$1.81B |
| 4 |
Otis Worldwide
OTIS
|
+$1.67B |
| 5 |
Carrier Global
CARR
|
+$1.43B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$3.74B |
| 2 |
RTN
Raytheon Company
RTN
|
+$2.93B |
| 3 |
Vanguard S&P 500 ETF
VOO
|
+$1.67B |
| 4 |
CY
Cypress Semiconductor
CY
|
+$779M |
| 5 |
iShares MBS ETF
MBB
|
+$772M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.92% |
| 2 | Healthcare | 14.84% |
| 3 | Financials | 12.13% |
| 4 | Consumer Discretionary | 10.93% |
| 5 | Communication Services | 8.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3526
Avalo Therapeutics
AVTX
$1.06B
| $4.5M | ﹤0.01% |
601
+158
| +36% | +$1.15M |
|
|
AVEO
3527
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
| $4.49M | ﹤0.01% |
871,976
+638,886
| +274% | +$4.03M |
|
|
SAL
3528
DELISTED
Salisbury Bancorp, Inc.
SAL
| $4.49M | ﹤0.01% |
218,860
+213,572
| +4,039% | +$3.88M |
|
3529
Stratasys
SSYS
$771M
| $4.47M | ﹤0.01% |
281,938
-3,037,963
| -92% | -$51.4M |
|
3530
Plumas Bancorp
PLBC
$428M
| $4.43M | ﹤0.01% |
200,311
+192,492
| +2,462% | +$3.73M |
|
|
TCS
3531
DELISTED
THE CONTAINER STORE GROUP, INC.
TCS
| $4.4M | ﹤0.01% |
90,626
+12,091
| +15% | +$467K |
|
3532
Oak Valley Bancorp
OVLY
$280M
| $4.4M | ﹤0.01% |
346,674
+40
| +0% | +$533 |
|
3533
Capital Bancorp
CBNK
$611M
| $4.39M | ﹤0.01% |
410,162
-34,360
| -8% | -$371K |
|
3534
Colony Bankcorp
CBAN
$468M
| $4.38M | ﹤0.01% |
372,021
-32,437
| -8% | -$377K |
|
|
LEVL
3535
DELISTED
Level One Bancorp, Inc. Common Stock
LEVL
| $4.37M | ﹤0.01% |
261,118
-19,791
| -7% | -$344K |
|
|
AGFS
3536
DELISTED
AgroFresh Solutions Inc
AGFS
| $4.37M | ﹤0.01% |
1,441,398
+1,233,009
| +592% | +$3.05M |
|
3537
Willis Lease Finance
WLFC
$1.21B
| $4.36M | ﹤0.01% |
538,884
-15,966
| -3% | -$114K |
|
3538
Ponce Financial Group
PDLB
$494M
| $4.35M | ﹤0.01% |
596,453
-66,620
| -10% | -$437K |
|
3539
Golub Capital BDC
GBDC
$3.41B
| $4.35M | ﹤0.01% |
373,421
+35,113
| +10% | +$395K |
|
|
ALR
3540
DELISTED
AlerisLife Inc
ALR
| $4.35M | ﹤0.01% |
1,115,560
+801,102
| +255% | +$2.86M |
|
3541
Santander
BSBR
$43.7B
| $4.33M | ﹤0.01% |
867,034
+16,073
| +2% | +$77.6K |
|
|
STMB
3542
DELISTED
iShares Factors US Mid Blend Style ETF
STMB
| $4.33M | ﹤0.01% |
+150,000
| New | +$4.11M |
|
|
STLC
3543
DELISTED
iShares Factors US Blend Style ETF
STLC
| $4.31M | ﹤0.01% |
+150,000
| New | +$4.08M |
|
3544
CB Financial Services
CBFV
$190M
| $4.29M | ﹤0.01% |
196,725
+176,869
| +891% | +$3.95M |
|
3545
Orion Energy Systems
OESX
$80.7M
| $4.29M | ﹤0.01% |
124,057
+110,204
| +796% | +$4.51M |
|
|
ETNB
3546
DELISTED
89bio
ETNB
| $4.26M | ﹤0.01% |
213,977
-3,771
| -2% | -$91.7K |
|
|
ORTX
3547
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
| $4.26M | ﹤0.01% |
70,990
+34,915
| +97% | +$3.2M |
|
|
WNS
3548
DELISTED
WNS Holdings
WNS
| $4.25M | ﹤0.01% |
77,310
-42,575
| -36% | -$2.03M |
|
|
AXLA
3549
DELISTED
Axcella Health Inc. Common Stock
AXLA
| $4.21M | ﹤0.01% |
30,463
+16,804
| +123% | +$2.06M |
|
3550
Mistras Group
MG
$579M
| $4.21M | ﹤0.01% |
1,065,940
-216,913
| -17% | -$898K |
|
Similar funds
BlackRock's Q2 2020 Portfolio in Review
As of Q2 2020, BlackRock held 5,263 positions worth $2.51T, up 23% from $2.04T the previous quarter. Its ten largest holdings account for 19% of the portfolio.
BlackRock's Q2 2020 filing shows 247 new, 2,443 increased, 1,910 reduced and 215 closed positions. Its largest new stake was Otis Worldwide: 32,136,910 shares worth $1.83B. The largest sale was Allergan plc, an estimated $3.74B.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.
- BlackRock's largest Q2 2020 buy was Otis Worldwide: 32,136,910 shares worth $1.83B.
- BlackRock added most to Amazon in Q2 2020, an estimated $2.16B increase.
- BlackRock's biggest Q2 2020 reduction was Vanguard S&P 500 ETF, cutting an estimated $1.67B.
- BlackRock fully exited Allergan plc in Q2 2020, selling an estimated $3.74B.
- BlackRock's ten largest holdings make up 19% of its $2.51T portfolio in Q2 2020.
- BlackRock opened 247 new positions and closed 215 in Q2 2020.
- BlackRock's portfolio value rose 23% quarter-over-quarter to $2.51T.
Based on BlackRock's 13F filing for Q2 2020, filed 14 Aug 2020.